Please enable JavaScript to continue using this application.

Compare $HOWL vs $HRGN | Chartloom

Compare

$HOWL vs $HRGN

Werewolf Therapeutics Inc · Harvard Apparatus Regenerative Technology Inc

HOWL

Werewolf Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Compare $HOWL vs $HRGN

Comparing Werewolf Therapeutics Inc and Harvard Apparatus Regenerative Technology Inc

HOWLWerewolf Therapeutics Inc

HRGNHarvard Apparatus Regenerative Technology Inc

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HOWL

HRGN

Detailed metrics comparison

HOWL

Werewolf Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

HOWL$48M

HRGN$40M

Enterprise Value

HOWL$26M

HRGN$41M

Price

HOWL$0.98

HRGN$2.30

P/E Ratio

HOWLN/A

HRGNN/A

P/S Ratio

HOWL2.27x

HRGN41.18x

EV/Sales

HOWL1.22x

HRGN41.33x

EV/EBITDA

HOWL0.00x

HRGN0.00x

P/B Ratio

HOWL2.77x

HRGN507.11x

P/FCF Ratio

HOWLN/A

HRGNN/A

EV/FCF

HOWL-0.85x

HRGN-11.16x

PEG Ratio

HOWLN/A

HRGNN/A

Forward P/E (NTM)

HOWLN/A

HRGNN/A

Forward P/S (NTM)

HOWLN/A

HRGNN/A

Revenue (TTM)

HOWL$21M

HRGN$982K

Revenue Growth (YoY)

HOWLN/A

HRGN44.6%

Forward Rev Growth

HOWL0.0%

HRGN0.0%

Gross Margin (TTM)

HOWL0.0%

HRGN7.5%

Operating Margin (TTM)

HOWL18.1%

HRGN0.0%

EBITDA Margin (TTM)

HOWL-104.4%

HRGN-682.9%

Net Margin (TTM)

HOWL-164.8%

HRGN-680.5%

FCF Margin (TTM)

HOWL-143.6%

HRGN-370.2%

Net Income (TTM)

HOWL$-35M

HRGN$-7M

FCF (TTM)

HOWL$-30M

HRGN$-4M

EPS (TTM)

HOWL-$0.71

HRGN-$0.38

ROE (TTM)

HOWL-16698.0%

HRGN-78637.0%

ROA (TTM)

HOWL-5988.0%

HRGN-30701.0%

ROIC (TTM)

HOWL-8259.0%

HRGN-77233.0%

Cash

HOWL$22M

HRGN$351K

Debt

HOWL$0

HRGN$500K

Net Cash/Debt

HOWL$22M

HRGN$-149K

Current Ratio (TTM)

HOWL2.91x

HRGN0.26x

Quick Ratio (TTM)

HOWL2.80x

HRGN0.12x

Debt/Equity (TTM)

HOWL1.14x

HRGN0.00x

Debt/Assets (TTM)

HOWL0.0%

HRGN0.0%

Interest Coverage (TTM)

HOWLN/A

HRGNN/A

Net Debt/EBITDA (TTM)

HOWL0.00x

HRGN0.00x

Beta

HOWL0.57

HRGN-0.50

52W Performance

HOWL-47.9%

HRGN-15.8%

YTD Performance

HOWL51.9%

HRGN16.2%

% from 52W High

HOWL-49.4%

HRGN-21.2%

% from 52W Low

HOWL262.8%

HRGN145.8%

Asset Turnover (TTM)

HOWL0.87x

HRGN0.45x

FCF Yield (TTM)

HOWL-63.3%

HRGN-9.0%

Earnings Yield (TTM)

HOWL-72.7%

HRGN-16.5%

Dividend Yield (TTM)

HOWLN/A

HRGNN/A

Rule of 40

HOWL-143.6

HRGN-325.5

EV/GP/RG

HOWLN/A

HRGNN/A

Ticker research

View HOWL research View HRGN research

Metric	HOWL Werewolf Therapeutics Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$48M	$40M
Enterprise Value	$26M	$41M
Price	$0.98	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	2.27x	41.18x
EV/Sales	1.22x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.77x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.85x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21M	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	18.1%	0.0%
EBITDA Margin (TTM)	-104.4%	-682.9%
Net Margin (TTM)	-164.8%	-680.5%
FCF Margin (TTM)	-143.6%	-370.2%
Net Income (TTM)	$-35M	$-7M
FCF (TTM)	$-30M	$-4M
EPS (TTM)	-$0.71	-$0.38
ROE (TTM)	-16698.0%	-78637.0%
ROA (TTM)	-5988.0%	-30701.0%
ROIC (TTM)	-8259.0%	-77233.0%
Financial Health
Cash	$22M	$351K
Debt	$0	$500K
Net Cash/Debt	$22M	$-149K
Current Ratio (TTM)	2.91x	0.26x
Quick Ratio (TTM)	2.80x	0.12x
Debt/Equity (TTM)	1.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	-0.50
52W Performance	-47.9%	-15.8%
YTD Performance	51.9%	16.2%
% from 52W High	-49.4%	-21.2%
% from 52W Low	262.8%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.45x
FCF Yield (TTM)	-63.3%	-9.0%
Earnings Yield (TTM)	-72.7%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-143.6	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View HOWL research	View HRGN research

Valuation

P/S Ratio

HOWL

2.27x

HRGN

41.18x

EV/FCF

HRGN

-11.16x

HOWL

-0.85x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

Forward Revenue Growth

HOWL

0.0%

HRGN

0.0%

Profitability & performance

Gross Margin

HRGN

7.5%

HOWL

0.0%

ROE

HOWL

-16698.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

HOWL

-63.3%

52-Week Performance

HRGN

-15.8%

HOWL

-47.9%

Detailed metrics comparison

HOWL

Werewolf Therapeutics Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

Market Cap

HOWL$48M

HRGN$40M

Enterprise Value

HOWL$26M

HRGN$41M

Price

HOWL$0.98

HRGN$2.30

P/E Ratio

HOWLN/A

HRGNN/A

P/S Ratio

HOWL2.27x

HRGN41.18x

EV/Sales

HOWL1.22x

HRGN41.33x

EV/EBITDA

HOWL0.00x

HRGN0.00x

P/B Ratio

HOWL2.77x

HRGN507.11x

P/FCF Ratio

HOWLN/A

HRGNN/A

EV/FCF

HOWL-0.85x

HRGN-11.16x

PEG Ratio

HOWLN/A

HRGNN/A

Forward P/E (NTM)

HOWLN/A

HRGNN/A

Forward P/S (NTM)

HOWLN/A

HRGNN/A

Revenue (TTM)

HOWL$21M

HRGN$982K

Revenue Growth (YoY)

HOWLN/A

HRGN44.6%

Forward Rev Growth

HOWL0.0%

HRGN0.0%

Gross Margin (TTM)

HOWL0.0%

HRGN7.5%

Operating Margin (TTM)

HOWL18.1%

HRGN0.0%

EBITDA Margin (TTM)

HOWL-104.4%

HRGN-682.9%

Net Margin (TTM)

HOWL-164.8%

HRGN-680.5%

FCF Margin (TTM)

HOWL-143.6%

HRGN-370.2%

Net Income (TTM)

HOWL$-35M

HRGN$-7M

FCF (TTM)

HOWL$-30M

HRGN$-4M

EPS (TTM)

HOWL-$0.71

HRGN-$0.38

ROE (TTM)

HOWL-16698.0%

HRGN-78637.0%

ROA (TTM)

HOWL-5988.0%

HRGN-30701.0%

ROIC (TTM)

HOWL-8259.0%

HRGN-77233.0%

Cash

HOWL$22M

HRGN$351K

Debt

HOWL$0

HRGN$500K

Net Cash/Debt

HOWL$22M

HRGN$-149K

Current Ratio (TTM)

HOWL2.91x

HRGN0.26x

Quick Ratio (TTM)

HOWL2.80x

HRGN0.12x

Debt/Equity (TTM)

HOWL1.14x

HRGN0.00x

Debt/Assets (TTM)

HOWL0.0%

HRGN0.0%

Interest Coverage (TTM)

HOWLN/A

HRGNN/A

Net Debt/EBITDA (TTM)

HOWL0.00x

HRGN0.00x

Beta

HOWL0.57

HRGN-0.50

52W Performance

HOWL-47.9%

HRGN-15.8%

YTD Performance

HOWL51.9%

HRGN16.2%

% from 52W High

HOWL-49.4%

HRGN-21.2%

% from 52W Low

HOWL262.8%

HRGN145.8%

Asset Turnover (TTM)

HOWL0.87x

HRGN0.45x

FCF Yield (TTM)

HOWL-63.3%

HRGN-9.0%

Earnings Yield (TTM)

HOWL-72.7%

HRGN-16.5%

Dividend Yield (TTM)

HOWLN/A

HRGNN/A

Rule of 40

HOWL-143.6

HRGN-325.5

EV/GP/RG

HOWLN/A

HRGNN/A

Ticker research

View HOWL research View HRGN research

Metric	HOWL Werewolf Therapeutics Inc	HRGN Harvard Apparatus Regenerative Technology Inc
Market & Valuation
Market Cap	$48M	$40M
Enterprise Value	$26M	$41M
Price	$0.98	$2.30
P/E Ratio	N/A	N/A
P/S Ratio	2.27x	41.18x
EV/Sales	1.22x	41.33x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.77x	507.11x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.85x	-11.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21M	$982K
Revenue Growth (YoY)	N/A	44.6%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	7.5%
Operating Margin (TTM)	18.1%	0.0%
EBITDA Margin (TTM)	-104.4%	-682.9%
Net Margin (TTM)	-164.8%	-680.5%
FCF Margin (TTM)	-143.6%	-370.2%
Net Income (TTM)	$-35M	$-7M
FCF (TTM)	$-30M	$-4M
EPS (TTM)	-$0.71	-$0.38
ROE (TTM)	-16698.0%	-78637.0%
ROA (TTM)	-5988.0%	-30701.0%
ROIC (TTM)	-8259.0%	-77233.0%
Financial Health
Cash	$22M	$351K
Debt	$0	$500K
Net Cash/Debt	$22M	$-149K
Current Ratio (TTM)	2.91x	0.26x
Quick Ratio (TTM)	2.80x	0.12x
Debt/Equity (TTM)	1.14x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	-0.50
52W Performance	-47.9%	-15.8%
YTD Performance	51.9%	16.2%
% from 52W High	-49.4%	-21.2%
% from 52W Low	262.8%	145.8%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.45x
FCF Yield (TTM)	-63.3%	-9.0%
Earnings Yield (TTM)	-72.7%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-143.6	-325.5
EV/GP/RG	N/A	N/A
Ticker research	View HOWL research	View HRGN research